According to him, the staff of the Center hope that this vaccine will need to be vaccinated every three to four years.

“We are currently working on this, the vaccine will work against the H1N1 variant and against many other influenza variants, even possibly against the H5N1 bird flu,” TASS quoted Gunzburg as saying.

He clarified that the vaccine is designed in such a way that antibodies begin to be produced against the "stalk" of the flu, which contains parts common to all its viruses that "do not change from one strain to another."